RCMG Inc. for Human Health
RCMG’s proprietary technology platform is able to continually create novel biomarkers/in vitro diagnostics (IVDs) to detect specific disease conditions suitable for the diversity of personalized medicine.
In the Glycoscience, new technologies based on engineering in addition to biochemistry and molecular biology promote new findings in medicine.
Hepatitis B virus (HBV), one of the most human infected viruses, has been a global health problem. A recombinant monoclonal antibody against HBsAg glycan isomer (HBsAgGi) was cloned and available from RCMG Inc.
Latest News
2025.5.20
RCMG Inc. is excited to announce its co-sponsorship of an Evening Seminar at the 62nd Annual Meeting of the Japan Society of Hepatology (June 18–19, 2026, Niigata).
2025.5.20
RCMG Inc. is pleased to announce that new data obtained using our “HBsAgGi ELISA” kit will be presented by Dr. Yuji Kita (Professor Takuya Genda’s group) from Juntendo University Shizuoka Hospital at the 62nd Annual Meeting of the Japan Society of Hepatology.
2025.5.20
RCMG Inc. is pleased to announce that new data obtained using our “HBsAgGi ELISA” kit will be presented by Dr. Shinya Maekawa (Professor Atsunori Tsuchiya’s group) from University of Yamanashi at the 62nd Annual Meeting of the Japan Society of Hepatology.
2025.5.20
RCMG Inc. is pleased to announce that new data obtained using our “HBsAgGi ELISA” kit will be presented by Dr. Kazumi Yamasaki from NHO Nagasaki Medical Center at the 62nd Annual Meeting of the Japan Society of Hepatology.
2025.5.20
RCMG Inc. is pleased to announce that new data obtained using our “HBsAgGi ELISA” kit will be presented by Dr. Hiroshi Yatsuhashi from NHO Nagasaki Medical Center at the 62nd Annual Meeting of the Japan Society of Hepatology. Notably, Dr. Yatsuhashi ‘s abstract has been selected as the Best Abstract of JSH62.
2025.3.14
RCMG Inc. was interviewed by the Nikkei (Nihon Keizai Shimbun) about our “HBsAgGi ELISA Kit,” an in vitro diagnostic drug for which we have obtained manufacturing and marketing approval in Japan.
2025.2.27
RCMG Inc. is pleased to announce that a special research article summarizing findings obtained using our “HBsAgGi ELISA” kit has been published in the journal “Kan Tan Sui” by Dr. Takuya Genda from Juntendo University Shizuoka Hospital, Dr. Hiroshi Yatsuhashi and Dr. Kazumi Yamasaki from NHO Nagasaki Medical Center.